Zobrazeno 1 - 10
of 173
pro vyhledávání: '"Sergiy M. Yarmoluk"'
Autor:
Mariia Yu. Rybak, Olga I. Gudzera, Oksana B. Gorbatiuk, Mariia O. Usenko, Sergiy M. Yarmoluk, Michael A. Tukalo, Galyna P. Volynets
Publikováno v:
ACS Omega, Vol 6, Iss 38, Pp 24910-24918 (2021)
Externí odkaz:
https://doaj.org/article/f4cf3581f4e74f23be2d69aafb9b0538
Autor:
Mariia Yu. Rybak, Anatoliy O. Balanda, Anna P. Yatsyshyna, Igor. M. Kotey, Sergiy A. Starosyla, Volodymyr G. Bdzhola, Lubov L. Lukash, Sergiy M. Yarmoluk, Michael A. Tukalo, Galyna P. Volynets
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Antibiotic resistance is a major problem of tuberculosis treatment. This provides the stimulus for the search of novel molecular targets and approaches to reduce or forestall resistance emergence in Mycobacterium tuberculosis. Earlier, we di
Externí odkaz:
https://doaj.org/article/2895faeaf24341efba42a3825c6db018
Autor:
Karsten Niefind, Nils Bischoff, Andriy G. Golub, Volodymyr G. Bdzhola, Anatoliy O. Balanda, Andriy O. Prykhod’ko, Sergiy M. Yarmoluk
Publikováno v:
Pharmaceuticals, Vol 10, Iss 1, p 9 (2017)
Protein kinase CK2 is associated with a number of human diseases, among them cancer, and is therefore a target for inhibitor development in industry and academia. Six crystal structures of either CK2α, the catalytic subunit of human protein kinase C
Externí odkaz:
https://doaj.org/article/ac6521b2a6bf47a397f7e9c6a82727ec
Autor:
Galyna P. Volynets, Fabian Barthels, Stefan J. Hammerschmidt, Olena V. Moshynets, Sergiy S. Lukashov, Sergiy A. Starosyla, Hanna V. Vyshniakova, Olga S. Iungin, Volodymyr G. Bdzhola, Andrii O. Prykhod’ko, Anatolii R. Syniugin, Vladislav M. Sapelkin, Sergiy M. Yarmoluk, Tanja Schirmeister
Publikováno v:
The Journal of Antibiotics. 75:321-332
Staphylococcus aureus is one of the most dangerous pathogens commonly associated with high levels of morbidity and mortality. Sortase A is considered as a promising molecular target for the development of antistaphylococcal agents. Using hybrid virtu
Autor:
Anna Iatsyshyna, Yaroslav V. Bilokin, S. S. Lukashov, Galyna P. Volynets, Volodymyr G. Bdzhola, Oleksiy Borovykov, L. L. Lukash, Sergiy M. Yarmoluk, V. S. Vdovin, Iryna Borysenko, Andrii Gryshchenko
Publikováno v:
Current Enzyme Inhibition. 17:161-165
Background: Overactivity of fibroblast growth factor receptor 1 (FGFR1) is associated with various tumors, particularly breast cancer, prostate cancer, non-small-cell lung carcinoma, myeloproliferative diseases, which makes this protein kinase a prom
Autor:
M. V. Protopopov, I. P. Borysenko, S. S. Lukashov, V. S. Vdovin, Sergiy M. Yarmoluk, O. V. Borovykov, Volodymyr G. Bdzhola
Publikováno v:
Biopolymers and Cell. 37:177-184
Autor:
Galyna P, Volynets, Olga I, Gudzera, Mariia O, Usenko, Oksana B, Gorbatiuk, Sergiy M, Yarmoluk, Michael A, Tukalo
Publikováno v:
Journal of biomolecular structuredynamics.
Methionyl-tRNA synthetase (MetRS) is an attractive molecular target for antibiotic discovery. Recently, we have developed several classes of small-molecular inhibitors of
Autor:
Galyna P, Volynets, Mariia O, Usenko, Olga I, Gudzera, Segiy A, Starosyla, Anatoliy O, Balanda, Anatolii R, Syniugin, Oksana B, Gorbatiuk, Andrii O, Prykhod'ko, Volodymyr G, Bdzhola, Sergiy M, Yarmoluk, Michael A, Tukalo
Publikováno v:
Future medicinal chemistry. 14(17)
Autor:
Sergiy M. Yarmoluk, Vladislav M. Sapelkin, Galyna P. Volynets, O. V. Savytskyi, Larysa V. Pletnova
Publikováno v:
Molecular Simulation. 47:1558-1568
Apoptosis signal-regulating kinase 1 (ASK1) has recently emerged as an attractive molecular target for pharmaceutical intervention. Several classes of small-molecular ASK1 inhibitors have been identified. In this article, we analysed the binding of s
Autor:
M. V. Protopopov, O. V. Borovykov, Sergiy M. Yarmoluk, V. S. Vdovin, Olga V. Ostrynska, I. P. Borysenko, S. S. Lukashov, Yaroslav V. Bilokin, Sergiy A. Starosyla, Olexander P. Kukharenko, Volodymyr G. Bdzhola
Publikováno v:
Biopolymers and Cell. 37:62-72